Rating History for Lineage Cell Therapeutics Inc. (LCTX) by D. Boral Capital
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/18/2024 | Jason Kolbert | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.86 (1.85) |
115.12% | Details |
